Oxytocin Disulfide Bond: Why Reduced and Oxidized Forms Need Separate LC-MS Records
Oxytocin is a nine-residue peptide whose Cys1 and Cys6 residues form an intramolecular disulfide bond. Reduction opens that ring and adds two hydrogen atoms to the molecular composition, but an intact-mass shift alone does not fully establish cysteine connectivity or sample history.
Start with the molecular form
The written sequence of oxytocin is CYIQNCPLG with an amidated C-terminus, commonly represented as a cyclic peptide through the Cys1–Cys6 disulfide. A record that lists only the nine residues omits two identity features: the disulfide state and terminal amide.
The PubChem oxytocin record provides a stable chemical-identity reference. A primary NIH PubMed thiol/disulfide study separated native disulfide and reduced dithiol forms of oxytocin-related peptides by reversed-phase HPLC and showed that the two forms can have different retention behavior. Those results belong to the stated conditions and do not validate an unrelated sample.
What reduction changes analytically
Breaking one disulfide adds two hydrogens across the two cysteine thiols, producing an approximate +2 Da neutral-mass difference. The conformational change may also alter chromatographic retention and ionization. A NIH PubMed MALDI study using oxytocin found that disulfide state can affect desorption and ionization efficiency, reinforcing that peak intensity is not a direct measure of molar amount across forms.
| Observation | Consistent interpretation | What it cannot prove alone |
|---|---|---|
| Approximate +2 Da after reduction | One disulfide may have been reduced | Original Cys1–Cys6 connectivity |
| Retention-time change | Chemical form or conformation changed | Exact identity without orthogonal evidence |
| New fragment ions after reduction | Previously linked regions became accessible | Quantitative purity |
| Different signal intensity | Ionization or recovery changed | More or less material without calibration |
The peptide stereochemistry and mass guide explains why matching nominal mass is only one layer of identity. For oxytocin specifically, the LC-MS sample-preparation article shows how extraction and recovery can affect the measured signal before structural interpretation begins.
A defensible disulfide-mapping design
Analyze nonreduced and reduced aliquots under controlled conditions. Preserve reagent identity, reaction time, temperature, pH, and alkylation details if free thiols are trapped. Compare intact mass, retention, and sequence-resolved fragments against a suitable reference. Controls should show whether the reducing reagent or matrix creates side reactions.
The key question is not merely whether cysteines exist. It is whether the data support the proposed linkage in the stated material. For a single intramolecular disulfide, combined nonreduced/reduced evidence may be straightforward, but intact mass still cannot distinguish every possible connectivity or mixed species without a mapping strategy.
The site’s currently published disulfide and redox examples include AOD-9604 and Glutathione in Research Compounds. They are separate molecules and should not inherit oxytocin evidence; they illustrate why connectivity and oxidation state belong to the exact material record. Lot-specific analytical fields should be checked in the COA library. The research documentation workflow provides the broader product-to-lot evidence chain.
Research limitations
Reduction can be incomplete, and disulfides can reform during handling. Adducts, isotope envelopes, matrix ions, and instrument resolution affect how a small mass change is observed. HPLC retention depends on method conditions. Published experiments on native or reduced oxytocin do not prove stability, purity, sterility, or biological activity for a commercial sample. This article covers analytical identity only.
Frequently asked questions
Is linear oxytocin the same material as disulfide-bonded oxytocin?
No. They share the residue order, but the disulfide state changes molecular composition and conformation and must be recorded separately.
Does a +2 Da shift prove reduction?
It is consistent with reduction of one disulfide, but reagent controls, retention behavior, and sequence-resolved evidence are needed to exclude alternatives.
Can HPLC alone locate the disulfide bond?
No. HPLC can separate species under a defined method; connectivity requires structural evidence designed to map the linked cysteines.
Why use both reduced and nonreduced analyses?
The paired comparison reveals changes caused by opening the disulfide and can improve fragment coverage while preserving evidence about the starting form.